Index of reports
> Cases with Malaise (77)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Rebetol (Ribavirin) where reactions include malaise. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 77 Next >>
Possible Rebetol side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Malaise, Renal Impairment, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, unk
Indication: Hepatitis C
Start date: 2012-06-06
Rebetol
Dosage: 600 mg, unk
Administration route: Oral
Start date: 2012-06-15
End date: 2012-06-20
Rebetol
Dosage: 200 mg, unk
Administration route: Oral
Start date: 2012-06-21
End date: 2012-07-12
Rebetol
Dosage: 800 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-06
End date: 2012-06-14
Rebetol
Dosage: 200 mg, qod
Administration route: Oral
Start date: 2012-07-13
Telavic
Dosage: 1500 mg, unk
Administration route: Oral
Start date: 2012-06-08
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-06
End date: 2012-06-07
Other drugs received by patient: Lendormin; Lansoprazole; Amoban
Possible Rebetol side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Malaise
Drug(s) suspected as cause:
PEG-Intron
Dosage: 100 microgram per kilogram, unk
Indication: Hepatitis C
Start date: 2012-06-15
End date: 2012-07-13
Rebetol
Dosage: 800 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-15
Rebetol
Dosage: 400 mg, unk
Administration route: Oral
Start date: 2012-07-06
End date: 2012-07-13
Telavic
Dosage: 2250 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-15
Telavic
Dosage: 1500 mg, unk
Administration route: Oral
Start date: 2012-07-06
End date: 2012-07-13
Other drugs received by patient: Diflunisal; Januvia; Basen
Possible Rebetol side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Drug Eruption, Haemoglobin Decreased, Malaise, Hyperglycaemia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-05-17
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-17
End date: 2012-06-13
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-06-14
End date: 2012-06-28
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-07-18
End date: 2012-07-26
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-17
End date: 2012-05-25
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Other drugs received by patient: Motilium; Gasmotin; Diflorasone Diacetate; Nizatidine
Possible Rebetol side effects in
Reported by a physician from United States on 2012-08-25
Patient:
Reactions: Weight Increased, Dysgeusia, Malaise, Hepatitis C, DRY Mouth
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2011-09-10
End date: 2012-03-24
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2011-09-10
End date: 2012-03-30
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2011-10-19
End date: 2012-03-30
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-23
Patient:
Reactions: Malaise, Skin Disorder, Idiopathic Thrombocytopenic Purpura
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Aldactone
Administration route: Oral
Amlodipine Besylate
Administration route: Oral
Lasix
Administration route: Oral
Ledolper
Dosage: 1 tablet per day , as needed
Administration route: Oral
Indication: Prophylaxis
Start date: 2012-02-07
Lickle
Administration route: Oral
Peginterferon Alfa-2B
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-02-07
End date: 2012-04-17
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-03-14
End date: 2012-03-27
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-07
End date: 2012-03-13
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-03-28
End date: 2012-04-19
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-07
End date: 2012-04-17
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-04-18
End date: 2012-04-19
Other drugs received by patient: Acetaminophen; Motilium; Rabeprazole Sodium; Gasmotin
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-23
Patient:
Reactions: Drug Eruption, Haemoglobin Decreased, Malaise, Hyperglycaemia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-05-17
Rebetol
Administration route: Oral
Rebetol
Dosage: 600 mg, once
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-17
End date: 2012-06-13
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-06-14
End date: 2012-06-28
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-17
End date: 2012-05-25
Telavic
Dosage: 1500 mg, once
Administration route: Oral
Start date: 2012-07-18
End date: 2012-07-26
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Other drugs received by patient: Gasmotin; Nizatidine; Motilium
Possible Rebetol side effects in
Reported by a physician from United States on 2012-08-23
Patient:
Reactions: Pruritus, Hypersensitivity, Contusion, Chills, Headache, Herpes Zoster, Vascular Injury, Fatigue, Malaise, Tongue Disorder, Candidiasis, Scratch, Swelling Face, Vomiting, Tongue Oedema, Nausea, Anaemia, Hypoaesthesia, Rash, Dysgeusia, Diarrhoea, Feeling Abnormal, Influenza
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-05-04
Rebetol
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-05-04
Valtrex
Dosage: unk unk, unknown
Indication: Herpes Zoster
Victrelis
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-06-01
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-23
Patient:
Reactions: White Blood Cell Count Decreased, Malaise, Vomiting, Nausea, Anaemia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Peginterferon Alfa-2B
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-04-18
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-18
End date: 2012-05-07
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-05-08
End date: 2012-05-08
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-05-09
End date: 2012-05-14
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-05-15
Telavic
Dosage: 2250 mg, qd,cumulative dose 4500 mg
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-18
End date: 2012-04-25
Telavic
Dosage: 1000 unk, unk,cumulative dose 4500 mg
Start date: 2012-06-13
End date: 2012-07-09
Telavic
Dosage: 1500 mg, qd,cumulative dose 4500 mg
Administration route: Oral
Start date: 2012-04-26
End date: 2012-06-12
Other drugs received by patient: Motilium; Eurax; Allegra; Clobetasol Propionate; Predonine; Predonine
Possible Rebetol side effects in
Reported by a physician from United States on 2012-08-23
Patient:
Reactions: White Blood Cell Count Decreased, Hepatitis C, Nausea, Anaemia, Rash, Headache, Dysgeusia, Irritability, Pruritus Generalised, Poor Quality Sleep, Malaise, Fatigue, Depression, Depressed Mood, Hypersomnia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 0.5 ml, unk
Indication: Hepatitis C
Start date: 2012-04-13
PEG-Intron
Dosage: 0.4 ml, unk
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-13
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-11
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-22
Patient:
Reactions: Malaise, Nausea, Anaemia, Insomnia, Depression, Rash, Constipation, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-02-01
End date: 2012-02-22
PEG-Intron
Dosage: 1.0mcg/kg/week
Start date: 2012-02-29
End date: 2012-02-29
PEG-Intron
Dosage: 0mcg/kg
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-01
End date: 2012-02-14
Rebetol
Administration route: Oral
Start date: 2012-02-15
End date: 2012-03-07
Rebetol
Administration route: Oral
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-01
End date: 2012-02-28
Telavic
Administration route: Oral
Start date: 2012-02-29
End date: 2012-03-07
Telavic
Administration route: Oral
Other drugs received by patient: [therapy Unspecified]; [therapy Unspecified]; Milmag; Senna-Mint WAF; [therapy Unspecified]
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-22
Patient:
Reactions: Malaise, Anaemia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-01-24
End date: 2012-07-10
Rebetol
Administration route: Oral
Start date: 2012-05-15
End date: 2012-05-28
Rebetol
Administration route: Oral
Start date: 2012-04-17
Rebetol
Administration route: Oral
Start date: 2012-05-29
Rebetol
Administration route: Oral
Start date: 2012-02-22
End date: 2012-04-16
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-24
End date: 2012-01-30
Rebetol
Administration route: Oral
Start date: 2012-01-31
End date: 2012-02-21
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-24
End date: 2012-01-27
Telavic
Administration route: Oral
Start date: 2012-01-28
End date: 2012-02-13
Telavic
Administration route: Oral
Start date: 2012-02-14
End date: 2012-02-16
Telavic
Administration route: Oral
Start date: 2012-02-17
End date: 2012-04-16
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-22
Patient:
Reactions: Malaise, Nausea
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-05-21
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-21
End date: 2012-06-17
Rebetol
Administration route: Oral
Start date: 2012-06-18
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-21
End date: 2012-06-24
Telavic
Administration route: Oral
Start date: 2012-06-25
Other drugs received by patient: Voltaren; Mucosta
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-22
Patient:
Reactions: Malaise, Blood Urea Increased, Blood Creatinine Increased, Decreased Appetite
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-06-13
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-13
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-13
End date: 2012-07-03
Telavic
Administration route: Oral
Start date: 2012-07-04
Possible Rebetol side effects in
Reported by a consumer/non-health professional from United States on 2012-08-22
Patient:
Reactions: Weight Decreased, Visual Acuity Reduced, Weight Increased, Blood Calcium Decreased, Malaise, Fatigue, Skin Ulcer, Blood Count, Back Pain, Dyspnoea, Nausea, Anaemia, DRY Skin, Rash, Paraesthesia, Pollakiuria, Asthenia
Drug(s) suspected as cause:
Pegasys
Dosage: 135 microgram, qw
Start date: 2011-11-01
End date: 2011-12-24
Pegasys
Dosage: 180 microgram, qw
Indication: Hepatitis C
Start date: 2011-07-11
Rebetol
Dosage: 800 mg, qd
Start date: 2011-11-01
End date: 2011-12-24
Rebetol
Dosage: 600 mg, unk
Start date: 2011-11-01
End date: 2011-12-24
Rebetol
Dosage: 1200, mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-07-11
Victrelis
Dosage: 800 mg, tid
Indication: Hepatitis C
Start date: 2011-08-08
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-22
Patient:
Reactions: Malaise
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-05-14
End date: 2012-06-18
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-14
End date: 2012-06-18
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-14
End date: 2012-06-14
Other drugs received by patient: Allegra; Urso 250; Epinastine Hydrochloride
Possible Rebetol side effects in
Reported by a consumer/non-health professional from United States on 2012-08-21
Patient:
Reactions: Pain, Anaemia, Furuncle, Headache, Myalgia, Dysgeusia, Fatigue, Malaise, Fungal Infection, Oral Candidiasis, Emotional Disorder, Feeling Abnormal
Drug(s) suspected as cause:
Peginterferon Alfa-2A
Dosage: 180 microgram, qw
Indication: Hepatitis C
Start date: 2012-03-23
Rebetol
Dosage: 1000 mg in divided dose (1 in 1 d)
Indication: Hepatitis C
Start date: 2012-03-23
Victrelis
Dosage: unk, tid
Indication: Hepatitis C
Start date: 2012-04-20
Other drugs received by patient: Wellbutrin
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-14
Patient:
Reactions: Malaise, Depression
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.3mcg/kg/week
Indication: Hepatitis C
Start date: 2012-05-29
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-29
Telavic
Administration route: Oral
Start date: 2012-07-04
Telavic
Administration route: Oral
Start date: 2012-05-29
End date: 2012-07-03
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-29
Other drugs received by patient: Olmesartan Medoxomil; Loxonin; Zolpidem; Rebamipide; Amlodipine
Possible Rebetol side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-14
Patient:
Reactions: Haemoglobin Decreased, Renal Impairment, Malaise, Anaemia, Rash, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Peginterferon Alfa-2B
Dosage: 80 ?g, qw
Start date: 2012-03-31
Peginterferon Alfa-2B
Dosage: 1.5 ?g/kg, qw
Indication: Hepatitis C
Start date: 2012-01-26
Peginterferon Alfa-2B
Dosage: 1.5 microgram per kilogram, qw
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-26
End date: 2012-02-29
Rebetol
Dosage: 200 mg, qd
Start date: 2012-07-12
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-03-08
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-03-15
End date: 2012-03-22
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-03-31
End date: 2012-04-06
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-03-01
End date: 2012-03-07
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-03-24
End date: 2012-03-30
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-04-19
End date: 2012-05-16
Rebetol
Dosage: 400 mg, qd
Start date: 2012-05-17
End date: 2012-07-11
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-03-08
End date: 2012-03-21
Telavic
Dosage: 1000 mg, qd
Administration route: Oral
Start date: 2012-03-24
End date: 2012-04-06
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-26
End date: 2012-03-07
Other drugs received by patient: Clobetasol Propionate; Sedekopan; Nespo; Allopurinol; Nespo; Paxil; Celestamine TAB
Possible Rebetol side effects in
Reported by a individual with unspecified qualification from Japan on 2012-08-14
Patient:
Reactions: Malaise
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 750 mg, qd
Administration route: Oral
Start date: 2012-05-15
Antiviral (Unspecified)
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-06
End date: 2012-05-14
Antiviral (Unspecified)
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-05-22
End date: 2012-05-24
PEG-Intron
Dosage: 50mcg
Start date: 2012-06-06
PEG-Intron
Dosage: 60 mcg/week
Indication: Hepatitis C
Start date: 2012-04-06
End date: 2012-05-02
PEG-Intron
Dosage: 50 mcg/week
End date: 2012-05-18
PEG-Intron
Dosage: 40 mcg/week
Start date: 2012-05-11
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-06
End date: 2012-04-25
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-04-26
End date: 2012-05-07
Rebetol
Administration route: Oral
Start date: 2012-06-14
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
End date: 2012-05-24
Telavic
Administration route: Oral
Start date: 2012-05-15
End date: 2012-05-21
Telavic
Administration route: Oral
Start date: 2012-05-22
End date: 2012-05-23
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-06
End date: 2012-05-14
Other drugs received by patient: Olmesartan Medoxomil; Olmesartan Medoxomil; Allopurinol
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-13
Patient:
Reactions: Malaise, Nausea
Drug(s) suspected as cause:
Peginterferon Alfa-2B
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-04-04
End date: 2012-05-02
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-04
End date: 2012-05-02
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-04
End date: 2012-05-02
Other drugs received by patient: Allegra; Voltaren-XR
Possible Rebetol side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient:
Reactions: Blood Pressure Increased, Malaise, Chest Discomfort, Anaemia, Dizziness, Renal Pain, Asthenia
Drug(s) suspected as cause:
Pegasys
Rebetol
Dosage: 2 df am and 3 df pm
Victrelis
Dosage: 4 df, unk
Administration route: Oral
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-10
Patient:
Reactions: Malaise, Rash
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-05-08
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-08
Rebetol
Administration route: Oral
Rebetol
Administration route: Oral
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-08
Telavic
Administration route: Oral
Start date: 2012-05-08
End date: 2012-07-11
Possible Rebetol side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient:
Reactions: Weight Decreased, Stomatitis, Nausea, Pain in Extremity, Pain, Bone Pain, Oral Discomfort, Dysgeusia, Haemoglobin Decreased, Fatigue, Malaise, DRY Mouth, Decreased Appetite, Influenza Like Illness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 microgram, unknown
Indication: Hepatitis C
Start date: 2012-02-07
Rebetol
Dosage: 600 mg, unknown
Indication: Hepatitis C
Start date: 2012-02-07
Victrelis
Dosage: 2400 mg, unknown
Indication: Hepatitis C
Start date: 2012-03-07
Other drugs received by patient: Geodon; Ferrous Sulfate TAB; Ambien; Promethazine; Prozac; Prilosec
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-02
Patient:
Reactions: Haemoglobin Decreased, White Blood Cell Count Decreased, Dysgeusia, Malaise, Haemolytic Anaemia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 100mcg/kg/week
Indication: Hepatitis C
Start date: 2012-03-22
PEG-Intron
Dosage: 1.5mcg/kg/week
Rebetol
Dosage: 600 mg, once
Administration route: Oral
Start date: 2012-04-18
End date: 2012-05-09
Rebetol
Dosage: 400 mg, once
Administration route: Oral
Start date: 2012-05-11
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-22
End date: 2012-04-17
Telavic
Administration route: Oral
Start date: 2012-04-18
End date: 2012-05-09
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-22
End date: 2012-04-17
Telavic
Administration route: Oral
Start date: 2012-05-11
End date: 2012-05-22
Other drugs received by patient: Marzulene-S; Nexium; Diovan; Azunol (Sodium Gualenate); Adalat CC; Mucosta
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-01
Patient:
Reactions: White Blood Cell Count Decreased, Malaise, Diarrhoea, Alopecia, Pancytopenia, Pyrexia, Headache, Neutrophil Count Decreased
Drug(s) suspected as cause:
Copegus
Dosage: 400 mg in the morning and 200 mg in the evening
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-12-27
Interferon Beta NOS
Indication: Hepatitis C
Start date: 2010-09-16
End date: 2010-09-21
Interferon Beta NOS
Start date: 2010-10-18
End date: 2010-12-24
Interferon Beta NOS
Start date: 2010-09-24
End date: 2010-10-16
Pegasys
Dosage: 180 qw
Indication: Hepatitis C
Start date: 2010-12-27
Rebetol
Dosage: 200 mg in the morning and 400 mg in the evening
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-09-16
End date: 2010-12-24
Other drugs received by patient: Alfarol; Singulair Tablets 10mg; Advair Diskus 100 / 50; Onealfa
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-01
Patient:
Reactions: Drug Eruption, White Blood Cell Count Decreased, Depressive Symptom, Pancytopenia, Dysgeusia, Haemoglobin Decreased, Malaise, Diarrhoea, Epistaxis, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 100mcg/week
Indication: Hepatitis C
Start date: 2012-02-02
End date: 2012-02-24
Rebetol
Administration route: Oral
Start date: 2012-02-29
End date: 2012-03-05
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-02
End date: 2012-02-28
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-02
End date: 2012-02-28
Telavic
Administration route: Oral
Start date: 2012-02-29
End date: 2012-03-05
Other drugs received by patient: Marzulene-S; Mucosta; Urso 250; Famotidine
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-08-01
Patient:
Reactions: Malaise, Platelet Count Decreased
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-04-03
End date: 2012-06-05
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-03
End date: 2012-06-05
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-03
End date: 2012-06-05
Other drugs received by patient: Antebate; Prednisolone; [therapy Unspecified]
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-07-31
Patient:
Reactions: Malaise, Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-02-29
End date: 2012-04-15
Antiviral (Unspecified)
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-17
End date: 2012-02-29
Paxil
Dosage: 3 df, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Paxil
Administration route: Oral
Indication: Adverse Event
Start date: 2012-02-01
PEG-Intron
Dosage: 80mcg/week
Indication: Hepatitis C
Start date: 2012-01-17
End date: 2012-02-01
PEG-Intron
Dosage: 1.0mcg/kg/week
Start date: 2012-04-16
End date: 2012-04-30
PEG-Intron
Dosage: 1.5mcg/kg/week
Start date: 2012-02-29
End date: 2012-04-15
PEG-Intron
Dosage: 1.5mcg/kg/week
Start date: 2012-05-01
PEG-Intron
Dosage: 50mcg/week
Start date: 2012-02-08
End date: 2012-02-15
Peginterferon Alfa-2B
Dosage: 1.5 ?g/kg, qw
Start date: 2012-02-29
End date: 2012-04-15
Peginterferon Alfa-2B
Dosage: 1.5 ?g/kg, qw
Start date: 2012-05-01
Peginterferon Alfa-2B
Dosage: 1.0 ?g/kg, qw
Start date: 2012-04-16
End date: 2012-04-30
Peginterferon Alfa-2B
Dosage: 50 ?g/kg, qw
Start date: 2012-02-08
End date: 2012-02-15
Peginterferon Alfa-2B
Dosage: 80 ?g/kg, qw
Indication: Hepatitis C
Start date: 2012-01-17
End date: 2012-02-01
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-17
End date: 2012-02-29
Rebetol
Administration route: Oral
Start date: 2012-02-08
End date: 2012-02-14
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-04-09
End date: 2012-04-15
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-05-07
End date: 2012-05-13
Rebetol
Administration route: Oral
Start date: 2012-02-15
End date: 2012-02-29
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-05-01
End date: 2012-05-06
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-05-14
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-02-29
End date: 2012-03-12
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-03-13
End date: 2012-04-08
Rebetol
Administration route: Oral
Start date: 2012-01-17
End date: 2012-02-07
Telavic
Administration route: Oral
Start date: 2012-02-29
End date: 2012-04-15
Telavic
Administration route: Oral
Start date: 2012-02-08
End date: 2012-02-14
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-17
End date: 2012-02-07
Telavic
Administration route: Oral
Start date: 2012-02-15
End date: 2012-02-29
Other drugs received by patient: HI-Z; [composition Unspecified]; Ganaton; Primeperani; Nizatidine; Talion (Bepotastine Besylate); Magmitt; Depas; Primeperani; Ganaton; Zolpidem; Loxonin; Dogmatyl; HI-Z
Possible Rebetol side effects in
Reported by a physician from Japan on 2012-07-31
Patient:
Reactions: Dysgeusia, Malaise, Hypoaesthesia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-04-11
End date: 2012-05-16
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-11
End date: 2012-05-22
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-11
End date: 2012-05-22
Possible Rebetol side effects in
Reported by a individual with unspecified qualification from Japan on 2012-07-31
Patient:
Reactions: Malaise, Nausea, Anaemia, Dizziness, Rash, Hyperuricaemia, Decreased Appetite
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-01
Antiviral (Unspecified)
Dosage: 750 mg, qd
Administration route: Oral
Start date: 2012-06-03
PEG-Intron
Dosage: 80 ?g, unknown
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-01
PEG-Intron
Dosage: 80mcg/kg/week
Indication: Hepatitis C
Start date: 2012-06-01
End date: 2012-06-22
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-01
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-01
End date: 2012-06-21
Rebetol
Administration route: Oral
Start date: 2012-06-22
End date: 2012-06-28
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-01
End date: 2012-06-06
Telavic
Administration route: Oral
Start date: 2012-06-07
End date: 2012-06-28
Other drugs received by patient: Levothyroxine Sodium; Levothyroxine Sodium; Lulicon; Equa; Amaryl; Metformin HCL; Aspara CA; Vitamin B12; Pravastatin
Page 1 Next >>
|